Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4098182

COc1ccc(C(=O)c2ccc(OCCc3ccc(OC)c(OC)c3)nc2)c(OC(C)(C)C(=O)O)c1.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARG P37231 10/20 0.41
PPARD Q03181 10/20 0.40
PPARA Q07869 10/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPC1 O15118 2/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
CYP4F2 P78329 1/20 0.38
CYP4A11 Q02928 1/20 0.38
MEN1 O00255 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4098190 0.90 LMNA (0.39) PPARGLMNAHTTSMN1; SMN2NPC1
Trifluoroacetic Acid SCHEMBL4099601 0.90 PPARG (0.44) PPARGPPARDPPARACYP4F2CYP4A11
Trifluoroacetic Acid SCHEMBL4093275 0.88 PPARG (0.47) PPARGPPARDPPARA
SCHEMBL4103465 0.87 PPARG (0.50) PPARGPPARDPPARANPC1
Trifluoroacetic Acid SCHEMBL4108534 0.87 PPARG (0.38) PPARGPPARDPPARANPC1CYP4F2
SCHEMBL4099680 0.86 PPARG (0.55) PPARGPPARDPPARALMNAHTT
Trifluoroacetic Acid SCHEMBL4103725 0.85 PPARA (0.40) PPARGPPARDPPARALMNANPC1
Trifluoroacetic Acid SCHEMBL4103434 0.84 PPARG (0.45) PPARGPPARDPPARALMNAHTT
Trifluoroacetic Acid SCHEMBL4102675 0.83 CYP11B1 (0.41) PPARGPPARDPPARACYP4F2CYP4A11
Trifluoroacetic Acid SCHEMBL4105730 0.83 POLB (0.39) PPARGPPARDPPARALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054435-A1 Phenoxyalkanoic Acid Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-02-26 US disclosed
EP-1911738-A1 PHENOXYALKANOIC ACID COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054435-A1 Phenoxyalkanoic Acid Compound PNLIP, GPR119, LIPC PPARG 23/4885PPARD 30/4885PPARA 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.